On April 22-24, NORMACOR was presented at the exhibition "RUSSIAN HEART DAYS -2021" in St. Petersburg

One of the most significant events of the year for cardiologists and cardiac surgeons took place at the Almazov National Research Medical Center. At least 2,800 open-heart surgeries are performed here annually, and most of them are performed using blood cardioplegic techniques.

NORMACOR is the flagship of blood thermal cardioplegia in Russia, as the drug is able to protect the patient's heart throughout the operation, and is officially registered as a medicinal product.